Biotech News: Mirror to Biotech Academia & Industry

Biotech news from India and across the globe. One stop site for your daily dose of Biotech industry , academia news and latest collaborations

India is set to be the third biggest global player in biotechnology and vaccine production by 2025, Union Minister for Science and Technology Harsh Vardhan has said.

The Himachal Pradesh government has formed a task force for the formulation of biotechnology-related policies and implementing them.

A University of Melbourne-led research team has cracked the riddle of how flu-killing immunity cells memorize distinct strains of influenza, which could lead to novel cellular memory-implant techno

Artificial pancreas, designed for blood glucose control in diabetes, face cyber security threats that could put users at risk, researchers, including one of Indian-origin, have warned.

Billionaire entrepreneur Patrick Soon-Shiong has raised $100 million for one of the many offshoots of his NantWorks conglomerate, working to duplicate the success of the targeted cancer drug that h

San Francisco-based biotech accelerator IndieBio has pledged to raise the funding per startup accepted into its program from $50,000 to $250,000 going forward.

While it's true that food- and water-borne bacteria cause untold illnesses and even death around the world, a team of researchers from the University of Tennessee, Knoxville, and Oak Ridge Nati

Kiran Mazumdar-Shaw, Chairperson of Asia's premier biopharmaceutical enterprise Biocon Ltd., has been ranked No.

The recently released Biotechnology policy (2015-2020) gave a big push to the sector offering a lot to improve the scope of sector in the country.

U.S agrochemical firm Monsanto has not yet giving up on th e proposed takeover of Swiss rival Syngenta. The initial offer of $45 billion by Monsanto was rejected.

While Environment Minister Prakash Javadekar is known to be aggressively pushing for more State Governments granting permission to hold field trials of genetically modified (GM) crops, the United S

iPhone could soon be more than just the thing to take selfies and make calls. Apple is planning to make iPhones into life saving device.

The Bill & Melinda Gates Foundation has committed an initial $75 million toward a new network of disease surveillance sites in developing countries.

36 new drugs were added to the list of essential medicines by the WHO which also includes the ground-breaking new treatment for hepatitis C and multi-drug resistant tuberculosis (TB).

University of Queensland researchers have found that around 12 taste receptors, particularly those that respond to bitter compounds, were expressed in human hearts.

Researchers have turned the humble onion to a tool to develop artificial muscles.

Google's stealthy biotech Calico is setting up shop inside the Buck Institute for Research on Aging in Novato, CA, after hammering out the latest in a long lineup of deals to collaborate on a n

WuXi Biologics, a wholly owned subsidiary of WuXi PharmaTech (Cayman) Inc., a R&D capability and technology platform company, has begun construction on a new US$150 million biologics manufactur

The global market for oncology drugs increased 10.3 percent last year and may reach $147 billion by 2018, according to IMS Health.

Adaptive Biotechnologies is helping scientists look at the immune system in a new way, with a combination of DNA sequencing and high-powered computation.

Doubling down on its in-house startup academy, biotech VC stalwart Flagship Ventures has recruited a trio of big-name corporate sponsors to lend their expertise to its next class of seedlings, expa

While the Narendra Modi government has moved swiftly on a range of environmental issues— approving long-delayed projects, arguably clearing the backlog inherited from the UPA and bringing in

Hyderabad, India, May 6, 2015: Mapmygenome India announced that their Spoligo TB™ in vitro diagnostic test kit for speedy detection and typing of large number of TB samples has been awarded t

The US pharma sector has welcomed India's recent moves on intellectual property, including bringing out a draft policy and sustained engagement, while regretting the consistent barriers posed b